The impact of body mass index (BMI) and body weight on hospitalization rates in haemodialysis patients is unknown.
A total of 3096 patients were hospitalized at least once with 9731 hospitalizations in total. Underweight haemodialysis patients were at increased risk of hospitalization, while overweight and obese patients were less likely to be hospitalized. Short-term weight loss in underweight individuals was associated with a strikingly high hospitalization rate. 
Riesgo de hospitalización asociado con el índice de masa corporal y los cambios de peso entre los pacientes de hemodiálisis prevalentes
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Marcadores nutricionales r e s u m e n El impacto del índice de masa corporal (IMC) y el peso corporal sobre las tasas de hospitalización en pacientes en hemodiálisis es desconocido.
La hipótesis del estudio es que tanto el bajo peso como la obesidad se asocian con un exceso de hospitalizaciones.
Estudio observacional que incluye 6.296 pacientes europeos de hemodiálisis con recolección prospectiva de datos y seguimiento cada 6 meses durante 3 años (estudio COSMOS 
Introduction
The relationship between protein energy wasting (PEW) and mortality in patients undergoing maintenance haemodialysis (HD) therapy is well documented. 1, 2 Paradoxical associations between various nutritional markers such as body mass index (BMI) and weight changes with mortality risk in HD patients have been described, showing better outcomes for those subjects with a higher BMI or that gain weight over time. [3] [4] [5] [6] [7] While hospitalization is an inherently limited outcome measure in etiological and prognostic research, it is a fundamental outcome for health-economy research and for research on the quality of clinical care. The risk of hospitalization increases in a graded manner by progressive CKD stage 8 and, for dialysis patients, it has been estimated to account for 40-60% of total healthcare expenditures. 9, 10 During the first year on dialysis, 77% of patients require hospitalization and spend 8.6% of patient treatment days in hospital. 11 Given the mounting epidemics of obesity and the parallel decline in underweight and malnutrition in the dialysis population, 12 identification of potentially modifiable hospitalization risk factors is important to improve the quality of clinical care in this population. Both malnutrition 13, 14 and obesity [15] [16] [17] are important causes of hospitalization in the community, with considerable economic and social cost implications, particularly for inpatient care. 18 Data concerning the association between nutritional parameters and hospitalization risk in HD patients are, however, scarce and mainly focused on the study of albumin levels. 11, [19] [20] [21] [22] We here address the association between BMI and short-term body weight changes with the hospitalization risk of dialysis patients. Given the parallel risk for hospitalization of extreme nutritional categories, we hypothesize that both obesity and underweight associate with higher hospitalization rates.
Methods

Study population
The Current Management of Secondary Hyperparathyroidism: A Multicentre Observational Study (COSMOS) is a multicentre, prospective and open cohort study with 3 years of followup including patients undergoing maintenance haemodialysis from 227 facilities in 20 European countries. The original aim of the cohort was to survey mineral and bone disturbances and related clinical practice patterns. Patients and facilities were randomly selected among a complete list of hospital and satellite dialysis centres from the 20 participating countries. The number of patients recruited in each country was proportional to its dialysis population, and each centre was expected to recruit 20 patients. COSMOS initially recruited 4500 patients and followed them up with data collections every six months for up to three years. Subject dying or leaving the study for other reasons (renal transplantation, change to a non-COSMOS facility or switch to peritoneal dialysis) during that period were replaced by 2297 new patients on haemodialysis for less than 1 year, totalling 6797. Recruitment took place between February 2005 and July 2007, and follow-up ended in July 2010. Study design and ethical approval, as well as random recruitment characteristics have been described in detail elsewhere. 23, 24 Demographic, clinical, and laboratory data Data on age, sex, height, post-HD weight, smoking (never, former or current smoker), diabetes mellitus, primary kidney disease, cardiovascular disease, country, type of facility (public or private) and haemodialysis-related variables (vintage, modality and hours per week) were collected when the patients entered the study. Data on weight, haemodialysis modality, and hours per week were collected every 6 months during the 3-year observation period. According to protocol design, weight was measured immediately after the haemodialysis session.
Hospitalization data
During the 3-year observation of the cohort, all occurring hospitalization events were registered for each patient every 6 months. Time to first hospitalization was collected and annual incidence rate were also calculated and used in the analyses evaluating the association between BMI, weight changes and the hospitalization risk.
Statistical design and analysis
Categorical variables are presented as percentage and continuous variables as mean ± SD or median (interquartile range), where appropriate. BMI was calculated as weight in kilograms divided by the square of height in meters. BMI was analyzed after stratification by 4 categories. According to the World Health Organization (WHO) guidelines, obesity was defined as a BMI ≥30 kg/m 2 , and overweight was defined as a BMI of 25-29 kg/m 2 . We defined normal weight as a BMI of 20-24 kg/m 2 , which is within the normal range according to the WHO, and underweight as a BMI <20 kg/m 2 . Normal weight was used, a priori, as the reference category. Weight changes over a 6-month period were calculated according to the difference between consecutive weight values, expressed as a percentage. Categorical analysis of weight change was established along previous analyses of BMI we performed in COSMOS 6 and 3 categories were identified weight loss (decreases >1%), weight gain (increases >1%) and stable weight (weight changes of less than ±1%). We chose this definition to allow comparison with preceding studies, 6, 25 where mortality associations were already observed for such small weight variations. Stable weight (within 1% variation) was considered the reference category.
In the analysis of hospitalization risks, both time-to-event analysis and incidence rates are clinically important and complementary outcomes. We performed time-dependent Cox proportional hazards regressions to assess the associations between 6-month BMI or weight changes and the risk to have one hospitalization. In these analyses patients were censored if undergoing renal transplantation (n = 382), death (n = 332), lost to follow-up (transfer to a non-COSMOS facility) (n = 136), change to peritoneal dialysis (n = 5) or end of the study, whichever occurred first. Data is presented as hazard ratios (HR) and 95% confidence intervals (CI). In addition, we used Poisson regression models to estimate the association between BMI or weight changes and the annual hospitalization rate versus the referent category, thus presenting data as incidence rate ratios (IRR) and 95% CI. In these analyses, we used either the baseline BMI or weight changes during the first 6 months of follow-up, and took into account all hospitalizations registered for each patient to estimate annual incidence rates. To both approaches, multivariate adjustment controlled for confounders including age, sex, smoking, country, type of haemodialysis centre, dialysis vintage, haemodialysis hours per week and modality. Covariates were considered as time-dependent when applicable, except sex, smoking, diabetes mellitus, cardiovascular disease, country, type of haemodialysis centre and primary kidney disease. Statistical significance was set at the level of P < 0.05. All statistical analyses were performed using STATA version 12.1 (Stata Corporation College Station, TX). 
Results
The present analysis included 6296 patients from COSMOS cohort, after excluding 485 patients (7.1%) who did not have follow-up data and 16 patients further lacking information on BMI. The majority of patients (94.5%) had undergone haemodialysis for more than 3 months. Baseline patient characteristics at study entry and incidence rates of hospitalization according to four BMI categories are displayed in Table 1 and published earlier. 6 Both underweight and obese patients had similar incidence rates of hospitalization and higher than normal and overweight patients.
BMI and the risk of hospitalization
During the 3-year follow-up, 3696 patients were hospitalized at least once, and a total of 9731 hospitalizations were registered in the cohort. The analysis of hazards to a first hospitalization considered a total of 17,797 observations through time-dependent analyses ( Table 2) . Underweight patients had a higher risk of hospitalization than patients with normal weight, while overweight and obese patients presented a non-statistically significant lower risk (model 2, Table 2 ). In the analysis of annual incidence rates, the association between baseline BMI and IRRs showed similar results (Fig. 1) ; 
Weight changes and the risk of hospitalization
Patients experiencing weight losses within a 6-month period were at higher risk of hospitalization than patients with stable weight. No association was seen in patients gaining weight IRR (95% CI) ( Table 3 ). When patients were stratified by their initial BMI, the risks estimates associated with weight losses were statistically significant and similar in magnitude across categories, with HR ranging from 1.88 and 2.04 (Fig. 2) . Patients experiencing weight losses during the first 6 months of follow-up had higher annual hospitalization rates (IRR) than individuals with stable body weight. Likewise, patients gaining weight had significantly lower hospitalization rates (Table 3) . When analyses were stratified by initial BMI categories, the magnitude of the association between dry weight losses and the hospitalization rates was similar among obese (IRR (Figure 2 ).
Discussion
Compared with other chronic illnesses, patients with CKD have more comorbidities, the highest annual number of inpatient stays, and the greatest number of hospital days. 26 Heart failure and ischaemic heart disease have been suggested as the top causes of hospitalization in this patient population. 8, 11 Poor nutritional status, as identified by hypoalbuminemia 11, [19] [20] [21] [22] may also contribute to explain such risk. To the best of our knowledge, this is the first study addressing the hospitalization risks associated with BMI and short-term body weight changes in this patient population.
Contrary to our working hypothesis which, along with mortality data, 6 envisaged an U-shaped relationship between the BMI and the risk of hospitalization, in COSMOS we found that BMI is inversely associated with the risk of hospitalization. Overweight and obese individuals were less likely to be hospitalized and presented a lower annual incidence rate of hospitalizations than normal weight patients. On the other hand, underweight individuals presented a higher relative risk of hospitalization. Even though a precious instrument to investigate the effect of nutritional status in epidemiological studies, BMI is an imperfect marker of fat mass excess both at a general population level 27 and in the dialysis population. [28] [29] [30] High BMI in part reflects high muscle mass, a body component which is of fundamental importance for determining disability in chronic diseases. 31, 32 Thus our analysis likely reflects the importance of frailty and sarcopenia in engendering clinical complications eventually leading to hospitalization in long-term dialysis. 33, 34 Some observational in our analysis may align with that hypothesis, such as the shorter dialysis vintage across higher BMI categories. In recent years, it has become apparent however that muscle quality and strength may be as important (or maybe more) as muscle mass. 35, 36 Independently of baseline nutritional status, intercurrent diseases leading to hospitalization have a relevant impact upon protein-energy metabolism in muscle mass. Accordingly, we found that short-term body weight losses have a Represented are unadjusted and adjusted hazard ratios and 95% confidence intervals for the risk of one hospitalization using time-dependent Cox regression analyses (every 6 months), and incidence rate ratios and 95% confidence intervals for calculation of annual hospitalization rates using Poisson regression analyses. Weight changes are considered as weight loss (decreases in weight higher that 1%), weight gain (increases in weight higher than 1%) and stable weight (weight changes of ±1%), taken here as the reference category. Adjusted model includes multivariate adjustment for age, sex, smoking (never, former or current), country, type of centre (public or private), dialysis vintage, haemodialysis hours per week and modality. clear-cut relationship with the risk of hospitalization, increasing it by two fold. In addition, in the long term, weight losses associated with approximately 50% higher annual hospitalization rates than those maintaining a stable body weight over time, in line with the hypothesis that sarcopenia and intercurrent PEW may underlie the excess risk for hospitalization in dialysis patients. Although it is possible that short term BMI changes in dialysis patients may in part reflect subclinical volume expansion, 37 BMI increases had just a minor, non-significant effect on the risk of hospitalization. Our findings need to be interpreted considering several strengths and limitations. Strengths include the prospective and careful cohort design (including their random recruitment), the completeness of data and the record of consecutive hospitalizations to allow the analysis of annual incidence rates. Its large sample size and representativeness of the European HD population should also be remarked. As discussed, BMI does feature several weaknesses as a metric of body fat in CKD patients. 38, 39 We lack information on length of hospital stay, which would have allowed us to make cost-effectiveness analysis, and we have unsatisfactory collection on hospitalization causes which limits our capacity to define them. A sensitivity analysis grouping countries according to global background hospitalization rates would have been preferred but was not feasible. In addition, we lack information on the intentionality of these body weight gains or losses. Given the short time frame studied (6-month periods) and the absence of consensus guidelines on weight loss programs for dialysis patients, we are assuming them to be unintentional. Other limitations are the ancillary nature of our findings, as well as the lack of information on additional surrogates of muscle and fat stores. 40 As in all observational cohort studies, residual confounding by unmeasured or unknown confounders may have played a role. The predominantly prevalent nature of the HD patients included in COSMOS makes it vulnerable to survivor bias despite the careful adjustment for dialysis vintage.
We conclude that both underweight (lower than 20 kg/m 2 in this analysis) and short-term body weight losses associate with increased hospitalizations rates, likely because it signals an unstable clinical situation including, but not limited to, an unfavourable nutritional status. This, and our previous report on hard endpoints, 6 altogether emphasize the importance of nutritional status on HD outcomes and bring special attention to the importance of the short-term weight losses in the underweight patients, a finding that deserves additional surveillance. The high and rising health cost absorbed by the dialysis population is a reason of concern for health authorities and providers. Since hospitalization has a major share in this cost, understanding the implication of nutritional disorders for this outcome may help to set strategies aimed at limiting hospital admission in this population. Cost-effectiveness studies indicate that, along with improved wellbeing, substantial savings in health costs can be obtained by protein and energy supplementation in treatment or prevention of malnutrition in the general population. 41 Analyses modelling the effect of such intervention on hospitalization in the dialysis population suggest that the potential savings in hospitalization, treatment costs and mortality may be substantial. 42, 43 Our observations provide further strength to the quest of performing clinical trials aimed at assessing whether nutritional interventions targeting body weight may improve clinical outcomes and reduce hospitalization in this high risk population. 
